Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Recurrent Fallopian Tube Cancer
Bordeaux, New Aquitaine
Recurrent Fallopian Tube Cancer Clinical Trials in Bordeaux, New Aquitaine
1 recruiting
Bordeaux, New Aquitaine, France
Showing
1–1
of
1
trials
Recruiting
Phase 1
Phase 2
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Endometrial Cancer
Recurrent Ovarian Cancer
Recurrent Fallopian Tube Cancer
+2 more
Regeneron Pharmaceuticals
890 enrolled
51 locations
NCT03564340
Feedback